glp-1 microdosing research What is Microdosing? | Health Matters GLP-1 microdosing is popular, but

Ongoing clinical and mechanistic studies are expected to expand use of GLP-1 receptor agonists, glucose-dependent insulinotropic polypeptide agonists and other metabolic hormones for the treatment of chronic kidney disease

Neurosci Biobehav Rev

There is a decent amount of literature showing that when people lose significant weight, some of that loss comes from muscle tissue

Hypoglycemia can occur when these agents are combined with insulin or sulfonylureas

Results compound over time think of it like strength training for your skin

Many people find that nausea is most bothersome in the morning or after going long periods without eating